HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report.

A significant increase (more than 10-fold) in the number of newly diagnosed HIV-1 infections among injecting drug users (IDUs) was observed in Greece during the first seven months of 2011. Molecular epidemiology results revealed that a large proportion (96%) of HIV-1 sequences from IDUs sampled in 2011 fall within phylogenetic clusters suggesting high levels of transmission networking. Cases originated from diverse places outside Greece supporting the potential role of immigrant IDUs in the initiation of this outbreak.

[1]  M. Salminen.  Letter to the editor: HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[2]  A. Hatzakis,et al.  Authors’ reply: HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report , 2011 .

[3]  N. Tordo,et al.  A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005-2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[4]  J. Parry,et al.  Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots , 2011, Journal of viral hepatitis.

[5]  N. Low,et al.  Mapping HIV/STI behavioural surveillance in Europe , 2010, BMC infectious diseases.

[6]  T. Hallett,et al.  HIV and risk environment for injecting drug users: the past, present, and future , 2010, The Lancet.

[7]  T. Rhodes,et al.  Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed , 2010, The Lancet.

[8]  J. Montaner,et al.  Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. , 2010, American journal of public health.

[9]  D. Krüger,et al.  Steep rise in notified hantavirus infections in Germany, April 2010. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  H. Leirs,et al.  Hantavirus outbreak in Western Europe: reservoir host infection dynamics related to human disease patterns , 2010, Epidemiology and Infection.

[11]  R. Hogg,et al.  Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. , 2010, Addiction.

[12]  R. D. Bruce.  Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings. , 2010, The International journal on drug policy.

[13]  A. Jeannin,et al.  HIV and STI behavioural surveillance among men who have sex with men in Europe. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[14]  Andrew Rambaut,et al.  Evolutionary analysis of the dynamics of viral infectious disease , 2009, Nature Reviews Genetics.

[15]  O. Pybus,et al.  Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach , 2009, Retrovirology.

[16]  S. Friedman,et al.  Theorizing "Big Events" as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks. , 2009, The International journal on drug policy.

[17]  Evan Wood,et al.  Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study , 2009, BMJ : British Medical Journal.

[18]  A. Vaheri,et al.  Hantavirus infections in Europe: from virus carriers to a major public-health problem , 2009, Expert review of anti-infective therapy.

[19]  D. D. Des Jarlais,et al.  Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia , 2009, Harm reduction journal.

[20]  P. Griffiths,et al.  HIV among injecting drug users in Europe: increasing trends in the East. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[21]  A. Kamarulzaman.  Global Epidemiology of Injecting Drug Use and HIV Among People Who Inject Drugs: A Systematic Review , 2008 .

[22]  A. Hatzakis,et al.  HIV epidemiology in Greece. , 2008, Future microbiology.

[23]  T. Leitner,et al.  Multiple HIV-1 introductions into the Swedish intravenous drug user population. , 2008, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[24]  A. Vaheri,et al.  Situation of hantavirus infections and haemorrhagic fever with renal syndrome in European countries as of December 2006. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[25]  H. Leirs,et al.  Hantavirus disease (nephropathia epidemica) in Belgium: effects of tree seed production and climate , 2008, Epidemiology and Infection.

[26]  A. Vaheri,et al.  How to diagnose hantavirus infections and detect them in rodents and insectivores , 2008, Reviews in medical virology.

[27]  D. D. Des Jarlais,et al.  HIV prevention for injecting drug users: the first 25 years and counting. , 2008, Psychosomatic medicine.

[28]  D. Kruger,et al.  Hemorrhagic Fever with Renal Syndrome Caused by 2 Lineages of Dobrava Hantavirus, Russia , 2008, Emerging infectious diseases.

[29]  D. Hedrich,et al.  From margin to mainstream: The evolution of harm reduction responses to problem drug use in Europe , 2008 .

[30]  Gkikas Magiorkinis,et al.  Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin. , 2007, The Journal of infectious diseases.

[31]  R. Coutinho,et al.  Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users , 2007, Addiction.

[32]  P Vickerman,et al.  Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study. , 2007, International journal of epidemiology.

[33]  A. Wodak,et al.  Do Needle Syringe Programs Reduce HIV Infection Among Injecting Drug Users: A Comprehensive Review of the International Evidence , 2006, Substance use & misuse.

[34]  J. Parry,et al.  HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years , 2005, AIDS.

[35]  H. Zeller,et al.  Larger than usual increase in cases of hantavirus infections in Belgium, France and Germany, June 2005. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[36]  D. Krüger,et al.  Central European Dobrava Hantavirus Isolate from a Striped Field Mouse (Apodemus agrarius) , 2005, Journal of Clinical Microbiology.

[37]  Tobi Saidel,et al.  Review of sampling hard-to-reach and hidden populations for HIV surveillance. , 2005, AIDS.

[38]  Michael P. Cummings,et al.  PAUP* [Phylogenetic Analysis Using Parsimony (and Other Methods)] , 2004 .

[39]  P. Griffiths,et al.  Surveillance of infectious diseases in IDUs across the EU: information from the EU expert network , 2004 .

[40]  M. Thomson,et al.  Identification of a Newly Characterized HIV‐1 BG Intersubtype Circulating Recombinant Form in Galicia, Spain, Which Exhibits a Pseudotype‐Like Virion Structure , 2002, Journal of acquired immune deficiency syndromes.

[41]  A. Mysterud,et al.  Population dynamics ofClethrionomys glareolus andApodemus flavicollis: seasonal components of density dependence and density independence , 2002, Acta Theriologica.

[42]  D. D. Des Jarlais,et al.  HIV surveillance among injecting drug users. , 2001, AIDS.

[43]  R. Brettle,et al.  Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997 , 2001, AIDS.

[44]  E. O. D. Op de Coul,et al.  HIV‐1 strains specific for Dutch injecting drug users inheterosexually infected individuals in The Netherlands , 1998, AIDS.

[45]  J. Weber,et al.  An HIV type 1 epidemic among injecting drug users in the former Soviet Union caused by a homogeneous subtype A strain. , 1997, AIDS research and human retroviruses.

[46]  B. Jędrzejewska,et al.  Rodent population dynamics in a primeval deciduous forest (Białowieża National Park) in relation to weather, seed crop, and predation , 1993 .

[47]  Crime.,et al.  WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users.. , 2009 .

[48]  T. Chassovnikarova,et al.  DISTRIBUTION AND HABITAT ASSOCIATION OF FIELD MOUSE (APODEMUS AGRARIUS PALLAS, 1771) IN NATIONAL PARK "STRANDJA" , 2005 .

[49]  K. Crandall,et al.  The causes and consequences of HIV evolution , 2004, Nature Reviews Genetics.

[50]  W. Gibson.  Zoonoses. Biology, clinical practice and public health control , 1998 .